NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/16/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
87 |
NOW APPROVED
Journey Medical Corporation Announces the U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg for Treatment of Papulopustular Rosacea.
Quarterly Reports
We use cookies to offer you a better browsing experience, including personalized advertising. By continuing to use the site you agree to their use.